98 related articles for article (PubMed ID: 33654172)
21. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
22. Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations.
Gonzalo S; Kreienkamp R; Askjaer P
Ageing Res Rev; 2017 Jan; 33():18-29. PubMed ID: 27374873
[TBL] [Abstract][Full Text] [Related]
23. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
24. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
McClintock D; Gordon LB; Djabali K
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
[TBL] [Abstract][Full Text] [Related]
25. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging?
Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II
Front Genet; 2019; 10():455. PubMed ID: 31156709
[TBL] [Abstract][Full Text] [Related]
26. Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome.
Kim PH; Luu J; Heizer P; Tu Y; Weston TA; Chen N; Lim C; Li RL; Lin PY; Dunn JCY; Hodzic D; Young SG; Fong LG
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257952
[TBL] [Abstract][Full Text] [Related]
27. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
28. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
29. Author Correction: Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1.
Zhang N; Hu Q; Sui T; Fu L; Zhang X; Wang Y; Zhu X; Huang B; Lu J; Li Z; Zhang Y
Nat Aging; 2023 Jun; 3(6):752. PubMed ID: 37130978
[No Abstract] [Full Text] [Related]
30. Progerin, the protein responsible for the Hutchinson-Gilford progeria syndrome, increases the unrepaired DNA damages following exposure to ionizing radiation.
Noda A; Mishima S; Hirai Y; Hamasaki K; Landes RD; Mitani H; Haga K; Kiyono T; Nakamura N; Kodama Y
Genes Environ; 2015; 37():13. PubMed ID: 27350809
[TBL] [Abstract][Full Text] [Related]
31. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
32. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
34. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
[TBL] [Abstract][Full Text] [Related]
35. Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells.
Bidault G; Garcia M; Capeau J; Morichon R; Vigouroux C; Béréziat V
Cells; 2020 May; 9(5):. PubMed ID: 32408587
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
[TBL] [Abstract][Full Text] [Related]
37. Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.
Saxena S; Kumar S
Geroscience; 2020 Apr; 42(2):467-494. PubMed ID: 32048129
[TBL] [Abstract][Full Text] [Related]
38. Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts.
Park SK; Shin OS
Exp Dermatol; 2017 Oct; 26(10):889-895. PubMed ID: 28192606
[TBL] [Abstract][Full Text] [Related]
39. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
[TBL] [Abstract][Full Text] [Related]
40. [Hutchinson-Gilford progeria in the light of contemporary genetics].
Madej-Pilarczyk A
Med Wieku Rozwoj; 2006; 10(1 Pt 2):355-62. PubMed ID: 17028399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]